Cite
Lupușoru G, Ailincăi I, Sorohan BM, et al. Serum soluble urokinase plasminogen activator receptor as a potential biomarker of renal impairment severity in diabetic nephropathy. Diabetes Res Clin Pract. 2021;182:109116doi: 10.1016/j.diabres.2021.109116.
Lupușoru, G., Ailincăi, I., Sorohan, B. M., Andronesi, A., Achim, C., Micu, G., Caragheorgheopol, A., Manda, D., Lupușoru, M., & Ismail, G. (2021). Serum soluble urokinase plasminogen activator receptor as a potential biomarker of renal impairment severity in diabetic nephropathy. Diabetes research and clinical practice, 182109116. https://doi.org/10.1016/j.diabres.2021.109116
Lupușoru, Gabriela, et al. "Serum soluble urokinase plasminogen activator receptor as a potential biomarker of renal impairment severity in diabetic nephropathy." Diabetes research and clinical practice vol. 182 (2021): 109116. doi: https://doi.org/10.1016/j.diabres.2021.109116
Lupușoru G, Ailincăi I, Sorohan BM, Andronesi A, Achim C, Micu G, Caragheorgheopol A, Manda D, Lupușoru M, Ismail G. Serum soluble urokinase plasminogen activator receptor as a potential biomarker of renal impairment severity in diabetic nephropathy. Diabetes Res Clin Pract. 2021 Dec;182:109116. doi: 10.1016/j.diabres.2021.109116. Epub 2021 Oct 30. PMID: 34728182.
Copy
Download .nbib